nach oben

World Journal of Urology

Erschienen in:

26.10.2015 | Original Article

Kidney cancer focal cryoablation trend: does location or approach matter?

verfasst von: O. Rodriguez Faba, F. Sanguedolce, P. Grange, G. Kooiman, A. Bakavicius, P. De la Torre, J. Palou

Erschienen in: World Journal of Urology | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We evaluated the current indications and surgical and survival outcomes for cryoablation (CA) using either a percutaneous (PCA) or a laparoscopic approach (LCA). We also investigated the ability of the PADUA score to predict the risk of complications and local recurrence.

Methods

A retrospective analysis was performed at two European tertiary referral centers. Parameters analyzed included size, location, approach, operative time, hospital stay, complications, and functional and oncologic outcomes. Univariate and multivariate analyses were performed. An ROC analysis was conducted to evaluate the accuracy of the PADUA score.

Results

Eighty patients were included. Mean tumor size was 2.6 cm. PCA was more often performed in posterior (95 vs. 60 %), inferior (72 vs. 32 %), and lateral (87 vs. 55 %) tumors. The global complication rate was 8.75 %, although proximity to the renal sinus resulted in a higher rate (30 vs. 4 %). Mean follow-up was 34 and 23 months for LCA and PCA, respectively. The 5-year recurrence-free survival was 76 and 90 % for LCA and PCA, respectively. Multivariate analysis showed that tumor involvement of the collecting system was predictive of recurrence. Under ROC analysis, PADUA score was a mild predictor for complications (AUC = 0.601) and a good predictor for recurrence (AUC = 0.723); PADUA ≥8 was identified as a cutoff for patients to a higher risk of recurrence.

Conclusions

The percutaneous approach is confirmed to be the preferred CA technique for posterior and lateral tumors. CA in deeper renal lesions and tumors with PADUA score ≥8 might entail a higher risk of recurrence, and closer follow-up should be considered in these patients.

Zargar H, Samarasekera D, Khalifeh A, Remer EM, O’Malley C, Akca O, Autorino R, Kaouk JH (2015) Laparoscopic versus percutaneous cryoablation for the small renal mass: 15-year experience at a single center. Urology 85(4):850–855. doi:10.1016/j.urology.2015.01.004 CrossRefPubMed

Hui GC, Tuncali K, Tatli S, Morrison PR, Silverman SG (2008) Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates. J Vasc Interv Radiol 19(9):1311–1320. doi:10.1016/j.jvir.2008.05.014 CrossRefPubMed

Bandi G, Hedican S, Moon T, Lee FT, Nakada SY (2008) Comparison of postoperative pain, convalescence, and patient satisfaction after laparoscopic and percutaneous ablation of small renal masses. J Endourol Soc 22(5):963–967. doi:10.1089/end.2007.0261 CrossRef

Ficarra V, Novara G, Secco S, Macchi V, Porzionato A, De Caro R, Artibani W (2009) Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol 56(5):786–793. doi:10.1016/j.eururo.2009.07.040 CrossRefPubMed

Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182(3):844–853. doi:10.1016/j.juro.2009.05.035 CrossRefPubMed

Chang X, Liu T, Zhang F, Qian C, Ji C, Zhao X, Liu G, Guo H (2015) The comparison of R.E.N.A.L., PADUA and centrality index score in predicting perioperative outcomes and complications following laparoscopic radiofrequency ablation of renal tumors. J Urol. doi:10.1016/j.juro.2015.03.095

Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Int Med 130(6):461–470CrossRefPubMed

Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD III, Dupuy DE, Gervais D, Gillams AR, Kane RA, Lee FT Jr, Livraghi T, McGahan J, Phillips DA, Rhim H, Silverman SG, Society of Interventional Radiology Technology Assessment C, International Working Group on Image-Guided Tumor A (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235(3):728–739. doi:10.1148/radiol.2353042205 CrossRefPubMedPubMedCentral

Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders P, Powles T, Staehler M, Volpe A, Bex A (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67(5):913–924. doi:10.1016/j.eururo.2015.01.005 CrossRefPubMed

10.

Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, Chen MH, Choi BI, de Baere T, Dodd GD III, Dupuy DE, Gervais DA, Gianfelice D, Gillams AR, Lee FT Jr, Leen E, Lencioni R, Littrup PJ, Livraghi T, Lu DS, McGahan JP, Meloni MF, Nikolic B, Pereira PL, Liang P, Rhim H, Rose SC, Salem R, Sofocleous CT, Solomon SB, Soulen MC, Tanaka M, Vogl TJ, Wood BJ, Goldberg SN, International Working Group on Image-guided Tumor A, Interventional Oncology Sans Frontieres Expert P, Technology Assessment Committee of the Society of Interventional R, Standard of Practice Committee of the C, Interventional Radiological Society of E (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology 273(1):241–260. doi:10.1148/radiol.14132958 CrossRefPubMedPubMedCentral

11.

Breda A, Lam JS, Riggs S, Leppert JT, Gui D, Said JW, Schulam PG, Belldegrun AS (2008) In vivo efficacy of laparoscopic assisted percutaneous renal cryotherapy: evidence based guidelines for the practicing urologist. J Urol 179(1):333–337. doi:10.1016/j.juro.2007.08.089 CrossRefPubMed

12.

Kaouk JH, Aron M, Rewcastle JC, Gill IS (2006) Cryotherapy: clinical end points and their experimental foundations. Urology 68(1 Suppl):38–44. doi:10.1016/j.urology.2005.12.050 CrossRefPubMed

13.

de Kerviler E, de Margerie-Mellon C, Coffin A, Legrand G, Resche-Rigon M, Ploussard G, Meria P, Mongiat-Artus P, Desgrandchamps F, de Bazelaire C (2015) The feasibility of percutaneous renal cryoablation under local anaesthesia. Cardiovasc Interv Radiol 38(3):672–677. doi:10.1007/s00270-014-0995-x CrossRef

14.

Badwan K, Maxwell K, Venkatesh R, Figenshau RS, Brown D, Chen C, Bhayani SB (2008) Comparison of laparoscopic and percutaneous cryoablation of renal tumors: a cost analysis. J Endourol Soc 22(6):1275–1277. doi:10.1089/end.2008.0102 CrossRef

15.

Long CJ, Canter DJ, Smaldone MC, Li T, Simhan J, Rozenfeld B, Teper E, Chen DY, Greenberg RE, Viterbo R, Uzzo RG, Kutikov A (2012) Role of tumor location in selecting patients for percutaneous versus surgical cryoablation of renal masses. Can J Urol 19(5):6417–6422PubMedPubMedCentral

16.

Rodriguez-Faba O, Palou J, Rosales A, de la Torre P, Marti J, Palazzetti A, Villavicencio H (2015) Prospective study of ultrasound-guided percutaneous renal cryotherapy: case selection as an optimization factor for a technique. Actas Urol Esp 39(1):8–12. doi:10.1016/j.acuro.2014.03.011 CrossRefPubMed

17.

Kim EH, Tanagho YS, Saad NE, Bhayani SB, Figenshau RS (2014) Comparison of laparoscopic and percutaneous cryoablation for treatment of renal masses. Urology 83(5):1081–1087. doi:10.1016/j.urology.2013.10.081 CrossRefPubMed

18.

Zargar H, Atwell TD, Cadeddu JA, de la Rosette JJ, Janetschek G, Kaouk JH, Matin SF, Polascik TJ, Zargar-Shoshtari K, Thompson RH (2015) Cryoablation for small renal masses: selection criteria, complications, and functional and oncologic results. Eur Urol. doi:10.1016/j.eururo.2015.03.027

19.

Klatte T, Shariat SF, Remzi M (2014) Systematic review and meta-analysis of perioperative and oncologic outcomes of laparoscopic cryoablation versus laparoscopic partial nephrectomy for the treatment of small renal tumors. J Urol 191(5):1209–1217. doi:10.1016/j.juro.2013.11.006 CrossRefPubMed

20.

Tang K, Yao W, Li H, Guo X, Guan W, Ma X, Zhang X, Zeng G, He W, Xu H, Ye Z (2014) Laparoscopic renal cryoablation versus laparoscopic partial nephrectomy for the treatment of small renal masses: a systematic review and meta-analysis of comparative studies. J Laparoendosc Adv Surg Tech Part A 24(6):403–410. doi:10.1089/lap.2013.0550 CrossRef

21.

Sisul DM, Liss MA, Palazzi KL, Briles K, Mehrazin R, Gold RE, Masterson JH, Mirheydar HS, Jabaji R, Stroup SP, L’Esperance JO, Wake RW, Rivera-Sanfeliz G, Derweesh IH (2013) RENAL nephrometry score is associated with complications after renal cryoablation: a multicenter analysis. Urology 81(4):775–780. doi:10.1016/j.urology.2012.11.037 CrossRefPubMed

22.

Okhunov Z, Shapiro EY, Moreira DM, Lipsky MJ, Hillelsohn J, Badani K, Landman J, Kavoussi LR (2012) R.E.N.A.L. nephrometry score accurately predicts complications following laparoscopic renal cryoablation. J Urol 188(5):1796–1800. doi:10.1016/j.juro.2012.07.028 CrossRefPubMed

23.

Blute ML Jr, Okhunov Z, Moreira DM, George AK, Sunday S, Lobko II, Vira MA (2013) Image-guided percutaneous renal cryoablation: preoperative risk factors for recurrence and complications. BJU Int 111(4 Pt B):E181–E185. doi:10.1111/j.1464-410X.2012.11538.x CrossRefPubMed

24.

Lagerveld BW, Brenninkmeijer M, van der Zee JA, van Haarst EP (2014) Can RENAL and PADUA nephrometry indices predict complications of laparoscopic cryoablation for clinical stage T1 renal tumors? J Endourol Soc 28(4):464–471. doi:10.1089/end.2013.0498 CrossRef

25.

Babaian KN, Okhunov Z, Juncal S, Ordon M, Lusch A, Zand T, Andreoni C, Landman J (2015) Clinical outcomes of patients with nondiagnostic biopsy during cryoablation of small renal masses. Urology 85(3):605–609. doi:10.1016/j.urology.2014.11.016 CrossRefPubMed

26.

Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolger GB, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Gupta S, Hancock SL, Kim JJ, Kuzel TM, Lam ET, Lau C, Levine EG, Lin DW, Michaelson MD, Olencki T, Pili R, Plimack ER, Rampersaud EN, Redman BG, Ryan CJ, Sheinfeld J, Shuch B, Sircar K, Somer B, Wilder RB, Dwyer M, Kumar R (2015) Kidney cancer, version 3.2015. J Natl Compr Cancer Netw JNCCN 13(2):151–159PubMed

27.

Tsivian M, Rampersaud EN Jr, del Pilar Laguna Pes M, Leveillee RJ, Shingleton WB, Aron M, Kim CY, DeMarzo AM, Desai MM, Meler JD, Donovan JF, Klingler HC, Sopko DR, Madden JF, Marberger M, Ferrandino MN, Polascik TJ (2014) Small renal mass biopsy–how, what and when: report from an international consensus panel. BJU Int 113(6):854–863. doi:10.1111/bju.12470 CrossRefPubMed

28.

Nielsen TK, Ostraat O, Andersen G, Hoyer S, Graumann O, Borre M (2015) Computed tomography contrast enhancement following renal cryoablation-does it represent treatment failure? J Endourol Soc. doi:10.1089/end.2015.0405

29.

Camacho JC, Kokabi N, Xing M, Master VA, Pattaras JG, Mittal PK, Kim HS (2015) R.e.N.a.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience. J Vasc Interv Radiol 26(5):686–693. doi:10.1016/j.jvir.2015.01.008 CrossRefPubMed

Titel: Kidney cancer focal cryoablation trend: does location or approach matter?
verfasst von: O. Rodriguez Faba
F. Sanguedolce
P. Grange
G. Kooiman
A. Bakavicius
P. De la Torre
J. Palou
Publikationsdatum: 26.10.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: World Journal of Urology / Ausgabe 7/2016
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-015-1716-z

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2016

A randomized controlled trial comparing alpha blocker (tamsulosin) and anticholinergic (solifenacin) in treatment of ureteral stent-related symptoms

A comparison between laparoscopic and retroperitoneoscopic approach for partial nephrectomy in children with duplex kidney: a multicentric survey

Manufacturers’ data show increasing implanted cylinder sizes and measured corporal lengths in inflatable penile implants

Nighttime kidney transplantation is associated with less pure technical graft failure